Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species

Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schalkwyk, Donelly A., Moon, Robert W., Duffey, Maëlle, Leroy, Didier, Sutherland, Colin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327131/
https://www.ncbi.nlm.nih.gov/pubmed/34315108
http://dx.doi.org/10.1016/j.ijpddr.2021.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327131/
https://www.ncbi.nlm.nih.gov/pubmed/34315108
http://dx.doi.org/10.1016/j.ijpddr.2021.07.002

Ejemplares similares